Direct-Acting Vasodilator — Hypertensive Emergency / Chronic Hypertension
Pregnancy: Used in pregnancy (pre-eclampsia) — relatively well-established safety; neonatal thrombocytopaenia reported with prolonged use
Hydralazine
Brand names: Apresoline
Adult dose
Dose: Hypertensive emergency: 5–10 mg IV slowly over 20 minutes; repeat after 20–30 min if needed; Chronic: 25 mg 2–3 times daily orally
Route: Intravenous (emergency) or oral (chronic)
Frequency: IV: repeat as needed (max 3–4 doses); Oral: 2–3 times daily
Max: IV: 20 mg per dose; Oral: 200 mg/day
IV hydralazine primarily used in hypertensive emergencies in pregnancy (eclampsia/pre-eclampsia) — labetalol or nifedipine now preferred in most UK guidelines. Oral: rarely used for chronic hypertension in UK (superseded by modern agents). Give with food (oral). Fast acetylators require higher doses.
Paediatric dose
Dose: 0.1–0.5 mg/kg IV mg/kg
Route: IV or oral
Frequency: Every 4–6 hours as needed
Max: 20 mg IV per dose
BNFc: used in hypertensive emergencies in children under specialist guidance
Dose adjustments
Renal
CrCl <30 mL/min: extend dosing interval (every 8–16 hours); slow acetylators accumulate more
Hepatic
Use with caution — hepatically metabolised by N-acetyltransferase
Paediatric weight-based calculator
BNFc: used in hypertensive emergencies in children under specialist guidance
Clinical pearls
- Drug-induced lupus is the major long-term risk — typically at doses >200 mg/day and in slow acetylators (NAT2 polymorphism); monitor ANA; usually reversible on stopping
- In pre-eclampsia: hydralazine IV was historical standard; NICE now recommends labetalol IV (first-line), nifedipine oral, or hydralazine IV — all equivalent; labetalol most predictable response
- Reflex tachycardia is significant — always co-prescribe beta-blocker in chronic use
- Dissecting aortic aneurysm: contraindicated — increased cardiac output worsens aortic wall stress; use beta-blocker + sodium nitroprusside instead
- Peripheral neuropathy with chronic use — supplement with pyridoxine (vitamin B6) 25 mg/day
Contraindications
- Idiopathic systemic lupus erythematosus (SLE) or drug-induced lupus
- Cor pulmonale
- Myocardial insufficiency due to mechanical obstruction
- Dissecting aortic aneurysm (increases cardiac output — dangerous)
Side effects
- Reflex tachycardia
- Headache
- Flushing
- Nausea
- Fluid retention
- Drug-induced lupus syndrome (>200 mg/day, slow acetylators — ANA positive)
- Peripheral neuropathy (pyridoxine deficiency)
- Hypotension
Interactions
- Beta-blockers — reduce reflex tachycardia (often co-prescribed)
- Other antihypertensives — additive hypotension
- MAOIs — enhanced hypotensive effect
Monitoring
- Blood pressure (continuous IV monitoring)
- Heart rate (reflex tachycardia)
- ANA and anti-dsDNA (long-term oral use)
- FBC (lupus-like blood dyscrasias)
Reference: BNFc; BNF 90; NICE NG133 (Hypertension in Pregnancy); Magee et al. NEJM 2015; NICE NG136. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- EDACS — Emergency Department Assessment of Chest Pain · Chest Pain
- San Francisco Syncope Rule · Syncope
- ROSE Rule for Syncope · Syncope
- Ottawa Heart Failure Risk Scale · Heart Failure
- Aortic Dissection Detection Risk Score (ADD-RS) · Aortic Disease
- REVEAL 2.0 Risk Score for Pulmonary Arterial Hypertension · Pulmonary Hypertension